HBM Partners is a private equity general partner firm headquartered in Zug, Switzerland.
Vitaeris, a Canada-based clinical-stage biopharmaceutical company, closed $7m in seed financing from HBM Healthcare Investments.
Allena Pharmaceuticals, a biopharmaceutical company focused on treating metabolic and orphan diseases, has closed $53m in Series C funding.
Nabriva Therapeutics, a VC-backed biopharmaceutical company focused on treating serious infections, has gone public.
Read more news concerning HBM Partners
A sampling of HBM Partners portfolio companies:
View all of the investments in their portfolio
Registration is fast, free and easy
Already a member?